chrisvoncsefalvay/vaers-outcomes huggingface dataset:
facial drop; chest pains/pressureweakness of limbshot face(no fever)facial dropmuscle spasmtingling in arms and faceswelling of throat(could still swallow/breath/speak); chest pains/pressure; chest pains/pressure; weakness of limbs; hot face (no fever); chest pains/pressureweakness of limbshot face(no fever)facial dropmuscle spasmtingling in arms and faceswelling of throat(could still swallow/breath/speak); tingling in arms and face; This is a spontaneous report from a contactable consumer.  A non-pregnant 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection),  dose 1 via an unspecified route of administration, administered on left arm on 24Mar2021 (Batch/Lot Number: EP7534) as 1st dose, single (at the age of 27 years old) for COVID-19 immunisation. The patient medical history included prior to vaccination, was the patient diagnosed with COVID-19?:Yes.  The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered on left arm on 24Mar2021 (Batch/Lot Number: EP7534) for COVID-19 immunisation. he patient's concomitant medications were not reported.  The patient experienced chest pains/pressure, weakness of limbs, hot face (no fever), facial drop, muscle spasm, tingling in arms and face and swelling of throat (could still swallow/breath/speak) on 01Apr2021 03:00. The patient received benadryl and saline solution. The patient was tested for as nasal swab and the result was negative on 21Apr2021. The outcome of the events was recovering. The patient received dose 2 via an unspecified route of administration, administered on right arm on 14Apr2021 (Batch/Lot Number: pfizer EW0162).   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Slight kind of dizziness kind of feeling; I got the inflammations all the different symptoms after I got the vaccine not before; This is a spontaneous report from a contactable consume reported that. 75-years-old patient of an unspecified gender received BNT162B2 (- BioNTech/Pfizer vaccine solution for injection), dose 1 via an unspecified route of administration, administered in Deltoid Left on 20May2021 (Batch/Lot Number: EW0185; Expiration Date: 31Jul2021) as DOSE 1, SINGLE for covid-19 immunization (Age at vaccination 75 years). The patient past medical history included blood cholesterol from an unknown date and unknown if ongoing and blood pressure measurement from an unknown date and unknown if ongoing. Concomitant medication(s) included atorvastatin (ATORVASTATIN) taken for blood cholesterol, start and stop date were not reported; hydrochlorothiazide, lisinopril (LISINOPRIL HCTZ) taken for blood pressure measurement, start and stop date were not reported. The patient reported after the COVID-19 Vaccine on last Thursday on unspecified date in May2021 the patient experienced have been having just slight dizziness kind of, I am trying to get an idea along this from last, there was another problem that I had is that I got the inflammations you know all the different symptoms after I got the vaccine not before, that's one problem And I am trying to understand along this here, my last everything else is alright, but I am just since like a very slight kind of dizziness kind of feeling. The event outcome was unknown.  Consumer schedule for second shot will be on 10Jun2021(left shoulder). When confirmed if consumer wanted information about having slight dizziness, consumer stated, "Yes, very slight, nothing serious. Consumer was provided the number of Pfizer Medical Information Department.  Follow-up attempts completed. No further information expected.
Weakness, Tired, Fever, Night Sweats, Elevated Heart Rate.  Normal resting heart rate is 55 bpm, elevated to 80 bpm. Fever 101.5.  Recovered to normal next day.
Moderate to severe stiffness in left elbow, left lower arm muscle tenderness to to the point of not able to pick up anything; Moderate to severe stiffness in left elbow, left lower arm muscle tenderness to to the point of not able to pick up anything; New onset of chills, fatigue, and loud ringing in left ear.; New onset of chills, fatigue, and loud ringing in left ear.; New onset of chills, fatigue, and loud ringing in left ear.; Day after administration:  Injection site soreness, muscle aches in shoulder; Day after administration:  Injection site soreness, muscle aches in shoulder; This is a spontaneous report received from a contactable consumer or other non-health care professional.  A 65-year-old female patient (non-pregnant) received bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection; Batch no: not reported /Lot Number: unknown) via unspecified route of administration, administered in Arm Left on 25Feb2021 (age at vaccination was 65 years) as dose 1, single for covid-19 immunization. The patient medical history included multiple sclerosis and covid-19 from an unknown, prior to vaccination and concomitant medications were not reported. Allergies to medications, food, or other products were reported as unknown. Prior to vaccination, the patient was diagnosed with COVID-19 and Since the vaccination, the patient has not been tested for COVID-19. It was unknown that patient received any other vaccines within 4 weeks prior to the COVID vaccine and patient received other medications within 2 weeks of vaccination with unknown names. On 26Feb2021 day after administration, the patient experienced Injection site soreness, muscle aches in shoulder and Approximately 3 days post administration patient had moderate to severe stiffness in left elbow, left lower arm muscle tenderness to the point of not able to pick up anything. 10 days post injection patient experienced with new onset of chills, fatigue, and loud ringing in left ear. No treatment was taken for the event. Outcome of the events Tenderness was resolving, and other events was not recovered.  No follow-up attempts are needed. No further information is expected.
Severe anaphylactic reaction with flushing, hypotension, tongue and facial swelling, airway obstruction and respiratory distress. Shock with SAO2 of 78, BP palpalble at 80 systolic and HR of 184.  Given 02 per mask at 8l/min, 2 xopenex inhalation treatments and benadryl 50 mg IM. No epi was given as pt. has carcinoid syndrome. As pt. remained unstable, she was transported via ambulance to the hospital where fluids, tagamet and prednisone were given.. Pt. stabilized and was sent home on prednisone and benadryl.  HPI:  Immediately after receiving the Pneumovax she began to experience anaphylactic symptoms of flushing through her face and body, and her throat beginning to swell. Tx'd with O2, Benadryl 50mg IM, and Xopenex nebs. O2 sats dropped to 87% on 6L of O2, but rose to 98% on room air prior to being sent via ambulance to the hospital. Pulse was 124 initially after the incident began but dropped to the 70's with treatment. Upon arrival in th ER, symptoms had improved, but still c/o a sensation of swelling in the back of her throat.  Discharged to home after several hours on steroids and benadryl.   Differential DX: anaphylaxis, allergic reaction, airway compromise.
small joint pain; This is a spontaneous report from a contactable consumer reporting for a patient. A 42-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number unknown and expiration date not provided), via an unspecified route of administration (anatomical location: arm left) on 31Dec2020 at SINGLE DOSE for covid-19 immunisation.  Medical history included was reported as none. The patient's concomitant medications were not reported. Patient was not pregnant at the time of vaccination. It was reported that patient experienced small joint pain on 31Dec2020. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
Chills and fever for 2+ hours; severe body aches for over 3 days; headache: nausea
This spontaneous report as received from a physician refers to a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unspecified date in 2008, the patient was vaccinated with the first dose of GARDASIL (dose, route of administration, lot#, expiration date were not reported). On 04-MAY-2015, the patient was vaccinated with the second dose of GARDASIL (dose, route of administration, lot#, expiration date were not reported) (Inappropriate schedule of drug administration). The physician thought that the second dose was quadrivalent. No adverse effect reported. Additional information has been requested.
Became COVID positive on February 4, 2022; Negative test result February 14, 2022.
Developed Shingles 17 days after first vaccine; This is a spontaneous report from a contactable nurse, the patient. A 50-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6203) via an unspecified route of administration in the left arm on 10Mar2021 at 00:00 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had unknown history of allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received medications within two weeks of vaccination, but the medications were unknown. On 26Mar2021 at 12:00, the patient developed shingles 17 days after first vaccine. The patient had to postpone second vaccine. The events resulted in emergency room/department visit or urgent care. Therapeutic measures were taken as a result of shingles and included treatment with Valtrex. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient is a 90-year-old male with a history of hypertension COPD and a remote history of A-fib presents to the emergency department with palpitations.  He states has had a for the last several days, he does have Cardizem at home to take as needed and he took them today however the palpitations continued so he came to the emergency department for evaluation.  He does state he is a little more short of breath when he is moving around.  No chest pain.  Patient did have COVID-19 was diagnosed approximately 7 days ago.  He states all symptoms have resolved however his palpitations seem to have happened after that.  No nausea or vomiting.  No diarrhea or constipation.  He states he is drinking plenty of fluids however eating less than he usually does since the COVID diagnosis. Associated Symptoms: palpitations, shortness of breath
RASH AT INJECTION SITE (dose 1 and 2) DOSE 1: I noticed a 3in diameter rash around the injection site of my vaccine on *day six or seven*. It was hot to the touch, itchy and sore to the touch. It lasted for seven to nine days, but did not lead me to seek medical treatment. DOSE 2: I noticed a 3in diameter rash around the injection site of my vaccine on *day two*. It was hot to the touch, itchy and sore to the touch. It lasted for seven to nine days, but did not lead me to seek medical treatment.  VAGINAL ULCER (dose 2 only) I had a 5mm diameter ulcer on the inside of my left labia minora. I began having pain two days after my vaccine, where it felt uncomfortable to wear underwear or tight pants, but it wasn't until the morning of the fourth day that I investigated the pain and saw the ulcer.  I went to a local urgent care in the afternoon of the fourth day, where the nurses took a surface swab of the ulcer, drew blood for an STD panel, and performed a Pap smear. I was given one week worth of valacyclovir, an antibiotic (which I do not remember the name of), and fluconazole to prevent a (or treat a possible) yeast infection.  I took one dose of valacyclovir the evening of the fourth day and the morning of the fifth day with no apparent improvement. I did not take any additional doses, as it was recommended by my provider that if it was not effective within 24 hours, then it may not be effective at all.  I took all doses of the antibiotic and fluconazole.  I began to see improvements (reduced pain, shrinking size) by the seventh day. The ulcer disappeared completely by the twelfth day.
Information was received from a licensed practical nurse referring to a 4 year old patient of unknown gender. The patient's concomitant medication, pertinent medical history and drug reactions were not reported. On 06-AUG-2018, the patient was vaccinated public funds at a private doctor's office/hospital with improperly stored doses of PROQUAD (lot # R002935, expiry date unknown) subcutaneously in the left arm and KINRIX (lot # 53NBZ, expiry date unknown) intramuscularly in the right deltoid. The patient previously received one dose of PROQUAD and "4 doses of DTaP and 3 doses of IPV". No prescription treatment was required for the experience. The temperature and time frame the vaccines exposed were unknown. Data logger was involved. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1808USA007644.
Following night noticed about 4in, by 3in area of swelling around injection site.(may have occured earlier, just first noticed then)  Complaining of soreness.  Treated with heat then and ice the following day (per doctors instructions) and swelling is going down.
Unknown if it?s is related or not. Terrible nausea which turned into vomiting and diarrhea for 8-12 hours.
needing support to move from one place to another; dizziness and light-headedness for 2 weeks already and is still experiencing it; the patient can not concentrate; This is a spontaneous report from a contactable pharmacist reported for a male patient. A 79-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection), dose 1 via an unspecified route of administration on 01Sep2021 (Lot number was not reported), as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in Sep2021, the patient experienced dizziness and light-headedness for 2 weeks already and is still experiencing it, needing support to move from one place to another, and the patient cannot concentrate. The clinical details of the events as follows: Caller had a patient who received the first dose of the Pfizer COVID-19 vaccine on 01Sep2021 and experienced dizziness and light-headedness for 2 weeks already and is still experiencing it. Caller stated that the patient wasdesperately trying to find a solution for that. Caller wanted more information on the side effects experienced by the patient and how to help the patient. The caller stated that it was the next morning that the side effects experienced by the patient started and that the patient could not concentrate and was needing support to move from one place to another. Caller also stated that the patient was a little bit better but not improving. The case was reported as non-serious. The patient outcome of the events was not resolved at the time of this report.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PATIENT COMPLAINED OF SEVERE DIZZINESS, DRUNK FEELING STARTING THE DAY FOLLOWING VACCINATION.  SHE WAS UNABLE TO GO TO WORK.
After injection, patient standing in room, states feels light headed, layed supine on bed, 1302: BP 80/40, scant diaphorsis, A/Ox4 pt states has a hx of passing out, rechecked BP 1305 100/62, states feels much better, sat up on bed for about 2 min., ambulated without difficulty, states feels fine, no symptoms, site without s/s of infection.
Patient reported tingling in arm at vaccination site and traveling. Also reported mild tingling in lips accompanied with feeling dizzy. Benadryl 25mg administered orally. Lungs were clear, 0 angioedema.SP02 was 96, pulse was 48 and rose to 80. blood pressure 127/74. Given snacks and declined an EMS call. went home with husband.
This spontaneous report as received from a healthcare worker refers to a patient of unspecified age and gender. No current or historical conditions were reported. On 13-NOV-2014 the patient was vaccinated with the third dose of ROTATE4Q (lot # K005394; expiration date: 23-FEB-2016, dosage information was not provided) orally, which was improperly stored (incorrect product storage). There were no concomitant medications reported. No adverse effect reported. There was no product quality complaint (PQC) involved. The outcome was unknown. This is one of several reports received from the same reporter. Additional information is not expected because the reporter had no further information available.
Left arm pain; Chills; Fatigue; Booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 09Dec2021 10:30 (Lot number: FJ8762) at the age of 51 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Atrial fibrillation" (unspecified if ongoing); "known allergies: Latex" (unspecified if ongoing). Concomitant medication(s) included: ELIQUIS. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EO6955, Location of injection: Left arm, Vaccine Administration Time: 04:00 PM, Route of Administration: Intramuscular), administration date: 14Apr2021, when the patient was 51 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EP6955, Location of injection: Left arm, Vaccine Administration Time: 11:00 AM, Route of Administration: Intramuscular), administration date: 22Mar2021, when the patient was 51 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 09Dec2021 10:30, outcome "unknown", described as "Booster"; PAIN IN EXTREMITY (non-serious) with onset 09Dec2021 22:00, outcome "recovered" (Dec2021), described as "Left arm pain"; CHILLS (non-serious) with onset 09Dec2021 22:00, outcome "recovered" (Dec2021), described as "Chills"; FATIGUE (non-serious) with onset 09Dec2021 22:00, outcome "recovered" (Dec2021), described as "Fatigue". Therapeutic measures were taken as a result of pain in extremity, chills, fatigue.  Additional information: patient did not receive any other vaccine in four weeks. Patient received treatment for the events with Tylenol. Patient was not diagnosed with covid prior to vaccination. since vaccination patient was not tested for covid.  No follow-up attempts are possible. No further information is expected.
Soreness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732), via an unspecified route of administration in the right arm on 25Mar2021 at 15:45 (at the age of 22-years-old), as a single dose for Covid-19 immunisation. Medical history was not reported. Concomitant medications included men multi-vitamin (MANUFACTURER UNKNOWN) and calcium carbonate, magnesium carbonate, magnesium trisilicate (TUMS); both taken for unknown indication started from an unknown date. The patient was allergic to cefpodoxime (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. On 26Mar2021, the patient experienced soreness at the injection site (vaccination site pain). In Mar2021, the patient was tested for SARS-CoV-2 test which resulted in negative. No therapeutic measures were taken as a result of soreness at injection site. The clinical outcome of the event soreness at injection site was resolved in Mar2021.   No follow-up attempts are needed. No further information is expected.
was sick every month for an entire year; my immune system tanked; Initial information received on 28-Oct-2021 regarding an unsolicited valid social media non-serious case from a consumer via.  This case involves Adult and unknown gender patient who experienced was sick every month for an entire year(illness) and my immune system tanked (Decreased immune responsiveness) while receiving vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  The patient's medical history, past medical treatments, vaccinations,Concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT]. batch number, expiry date not reported via unknown route in unknown administration site for prophylactic vaccination.   On an unknown date the patient experienced a non-serious was sick every month for an entire year (illness) (latency unknown) and experienced a non-serious my immune system tanked (decreased immune responsiveness) (latency unknown) following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  It was reported" I got the flu shot 20 years ago and my immune system tanked ... I was sick every month for an entire year. I've not taken the flu shot since and I have had the flu once in that time. Our immune system is powerful".  It is unknown if the patient experienced any additional symptoms/ events.   no Laboratory data was reported.   It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome of the reported event was unknown.  There will be no information on the batch number for this case.
This case was reported by a physician via call representative and described the occurrence of allergic reaction in a patient who received BOOSTRIX. Co-suspect products included HAVRIX. Concomitant products included MENVEO. On an unknown date, the patient received BOOSTRIX at an unknown dose and HAVRIX at an unknown dose. On an unknown date, an unknown time after receiving BOOSTRIX and HAVRIX, the patient experienced allergic reaction. The patient was treated with Antibiotic. On an unknown date, the outcome of the allergic reaction was unknown. It was unknown if the reporter considered the allergic reaction to be related to BOOSTRIX and HAVRIX. Additional information provided: The field representative received a call from an allergy office where a patient
patient reported flu like symptoms that started the next day after getting the shingrix shot. she was in bed for 2 days, drowsy, dizzy and can't function. Patient was planning to go to E.R., but with pandemic, decided to stay home. patient is feeling better now, almost a week later but not fully recovered. she still gets tired after doing some tasks. also patient had swelling around sight of injection that spread, but now is getting better.
Fever increased to 102 from Friday evening and finally broke Sunday around noon (rotated Tylenol and Ibruprofen).  Muscle and joint pain that is still ongoing. Not near as painful as the first 72 hours after vaccine, but still ache all over. Chills Headache - Different than cluster headaches and migraines. Began a few hours after receiving vaccine.